Reconceiving orphan drug market exclusivity as a conditional public-law entitlement: a sustainable regulatory governance model with comparative lessons for China
- DOI
- 10.3389/fmed.2026.1896433
- Published
- 2026-07-22
- Container
- Frontiers in Medicine
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fmed.2026.1896433,
title = {Reconceiving orphan drug market exclusivity as a conditional public-law entitlement: a sustainable regulatory governance model with comparative lessons for China},
author = {Guiyu Quan and Yi Zhou and Yi Liu and Yinan Wu and Yong Yan},
year = {2026},
journal = {Frontiers in Medicine},
doi = {10.3389/fmed.2026.1896433},
url = {https://doi.org/10.3389/fmed.2026.1896433}
}RIS
TY - JOUR TI - Reconceiving orphan drug market exclusivity as a conditional public-law entitlement: a sustainable regulatory governance model with comparative lessons for China AU - Guiyu Quan AU - Yi Zhou AU - Yi Liu AU - Yinan Wu AU - Yong Yan PY - 2026 JO - Frontiers in Medicine DO - 10.3389/fmed.2026.1896433 UR - https://doi.org/10.3389/fmed.2026.1896433 ER -
APA
Quan, G., Zhou, Y., Liu, Y., Wu, Y., & Yan, Y. (2026). Reconceiving orphan drug market exclusivity as a conditional public-law entitlement: a sustainable regulatory governance model with comparative lessons for China. Frontiers in Medicine. https://doi.org/10.3389/fmed.2026.1896433
Source records
- crossref · retrieved 2026-11-10T11:57:05.438Z